US FDA approves Inovio’s treatment for rare throat disease; shares surge

By Oct 30, 2026

Regulatory Approvals — US FDA approves Inovio's treatment for rare throat disease; shares surge Reuters

Read the original at Regulatory Approvals ↗

Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. October 30, 2026.

By

Regulatory Approvals

FDA Approves Tildrakizumab for Psoriatic Arthritis in Adults

Oct 30, 2026

Regulatory Approvals

October FDA Approvals Bring Advances Across 5 Specialties

Oct 30, 2026

Regulatory Approvals

FDA Approves First Immunotherapy for Locally Advanced Rectal Cancer

Oct 30, 2026

US FDA approves Inovio’s treatment for rare throat disease; shares surge

By

Financial News For All

Why companies offer buyouts versus layoffs

AI-driven layoffs are creating a new class of boomerang employees—companies are realizing they ‘pulled the plug too quickly’

FDA Approves First Immunotherapy for Locally Advanced Rectal Cancer

October FDA Approvals Bring Advances Across 5 Specialties

US FDA approves Inovio’s treatment for rare throat disease; shares surge

By

Related Post

FDA Approves Tildrakizumab for Psoriatic Arthritis in Adults

October FDA Approvals Bring Advances Across 5 Specialties

FDA Approves First Immunotherapy for Locally Advanced Rectal Cancer

Financial News For All

Why companies offer buyouts versus layoffs

AI-driven layoffs are creating a new class of boomerang employees—companies are realizing they ‘pulled the plug too quickly’

FDA Approves First Immunotherapy for Locally Advanced Rectal Cancer

October FDA Approvals Bring Advances Across 5 Specialties